OKYO Pharma LTD: OKYO Pharma Limited

LONDON and NEW YORK, May 18, 2022 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), a biotechnology company focused on the discovery and development of novel molecules to treat inflammatory

Related Keywords

United Kingdom ,London ,City Of ,Robert Emmet ,Gabriele Cerrone ,Garys Jacob ,London Stock Exchange ,Pharma Limited ,Redchip Companies Inc ,Optiva Securities ,Panetta Partners ,Nasdaq ,Panetta Partners Limited ,Executive Chairman ,Chief Executive ,Investor Relations ,Official List ,United Kingdom Financial Conduct Authority ,Dry Eye Disease ,Tokyo ,Dharma ,Imited ,Dmr ,Dealing ,